enVVeno Medical (NVNO) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $7.47, -5.74% vs the prior close of $7.93.
- Volume 67.60K shares, 2.5x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
NVNO slides 5.7% to $7.47 on 2.5x normal volume. Closed at $7.47, -5.74% vs the prior close of $7.93. Day range $7.30–$8.01, opened at $8.01.
NVNO daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — NVNO slides 5.7% to $7.47 on 2.5x normal volume
- Closed at $7.47, -5.74% vs the prior close of $7.93. Day range $7.30–$8.01, opened at $8.01.
- Volume was 67.60K shares, 2.5x its 50-day average of 27.15K — unusually heavy trading.
- Price is -23.2% vs its 50-day average ($9.72) and -29.2% vs its 200-day average ($10.56).
- 52-week range $7.01–$28.70; today's close sits at 2% of that range, 74.0% below the 52-week high.
Oct 15, 2026 — NVNO jumps 7.1% to $7.93
- Closed at $7.93, +7.09% vs the prior close of $7.40. Day range $7.27–$7.93, opened at $7.27.
- Volume was 41.80K shares, 1.6x its 50-day average of 26.34K.
- Price is -18.9% vs its 50-day average ($9.77) and -25.1% vs its 200-day average ($10.58).
- 52-week range $7.01–$28.70; today's close sits at 4% of that range, 72.4% below the 52-week high.
Oct 14, 2026 — NVNO slides 7.2% to $7.40, a 52-week low, 3 down days in a row
- Closed at $7.40, -7.15% vs the prior close of $7.97. Day range $7.18–$8.13, opened at $8.00.
- Volume was 18.90K shares, 0.7x its 50-day average of 26.25K.
- Price is -24.8% vs its 50-day average ($9.84) and -30.2% vs its 200-day average ($10.60).
- 52-week range $7.01–$28.70; today's close sits at 2% of that range, 74.2% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — NVNO dips 2.2% to $7.97 on 1.9x normal volume
- Closed at $7.97, -2.21% vs the prior close of $8.15. Day range $7.60–$8.65, opened at $8.65.
- Volume was 48.60K shares, 1.9x its 50-day average of 25.35K — unusually heavy trading.
- Price is -19.6% vs its 50-day average ($9.91) and -25.0% vs its 200-day average ($10.62).
- 52-week range $7.01–$28.70; today's close sits at 4% of that range, 72.2% below the 52-week high.
Oct 12, 2026 — NVNO slides 6.9% to $8.15 on 5.4x normal volume
- Closed at $8.15, -6.86% vs the prior close of $8.75. Day range $8.06–$8.80, opened at $8.80.
- Volume was 122.90K shares, 5.4x its 50-day average of 22.94K — unusually heavy trading.
- Price is -18.2% vs its 50-day average ($9.97) and -23.4% vs its 200-day average ($10.65).
- 52-week range $7.01–$30.80; today's close sits at 5% of that range, 73.5% below the 52-week high.
Oct 9, 2026 — NVNO jumps 7.0% to $8.75
- Closed at $8.75, +7.03% vs the prior close of $8.18. Day range $8.41–$9.58, opened at $8.41.
- Volume was 36.50K shares, 1.6x its 50-day average of 22.26K.
- Price is -12.6% vs its 50-day average ($10.02) and -18.0% vs its 200-day average ($10.66).
- 52-week range $7.01–$33.60; today's close sits at 7% of that range, 74.0% below the 52-week high.
Oct 8, 2026 — NVNO dips 2.7% to $8.18
- Closed at $8.18, -2.68% vs the prior close of $8.40. Day range $8.06–$8.48, opened at $8.41.
- Volume was 6.70K shares, 0.3x its 50-day average of 22.19K — lighter than usual.
- Price is -18.7% vs its 50-day average ($10.05) and -23.4% vs its 200-day average ($10.68).
- 52-week range $7.01–$35.17; today's close sits at 4% of that range, 76.8% below the 52-week high.
Oct 7, 2026 — NVNO rises 2.4% to $8.40
- Closed at $8.40, +2.44% vs the prior close of $8.20. Day range $7.91–$8.43, opened at $7.98.
- Volume was 15.10K shares, 0.7x its 50-day average of 21.94K.
- Price is -16.8% vs its 50-day average ($10.10) and -21.4% vs its 200-day average ($10.69).
- 52-week range $7.01–$35.17; today's close sits at 5% of that range, 76.1% below the 52-week high.
Oct 6, 2026 — NVNO rises 2.4% to $8.20
- Closed at $8.20, +2.37% vs the prior close of $8.01. Day range $7.96–$8.47, opened at $8.01.
- Volume was 36.80K shares, 1.7x its 50-day average of 21.26K.
- Price is -19.1% vs its 50-day average ($10.14) and -23.5% vs its 200-day average ($10.71).
- 52-week range $7.01–$35.17; today's close sits at 4% of that range, 76.7% below the 52-week high.
Oct 5, 2026 — NVNO dips 1.1% to $8.01
- Closed at $8.01, -1.11% vs the prior close of $8.10. Day range $7.75–$8.60, opened at $7.92.
- Volume was 10.60K shares, 0.5x its 50-day average of 21.12K — lighter than usual.
- Price is -21.4% vs its 50-day average ($10.19) and -25.4% vs its 200-day average ($10.73).
- 52-week range $7.01–$35.17; today's close sits at 4% of that range, 77.2% below the 52-week high.
Oct 2, 2026 — NVNO rises 0.7% to $8.10
- Closed at $8.10, +0.75% vs the prior close of $8.04. Day range $7.70–$8.78, opened at $8.11.
- Volume was 24.30K shares, 1.2x its 50-day average of 20.89K.
- Price is -20.9% vs its 50-day average ($10.23) and -24.6% vs its 200-day average ($10.75).
- 52-week range $7.01–$35.17; today's close sits at 4% of that range, 77.0% below the 52-week high.
NVNO latest news & SEC filings
Every SEC filing by or about NVNO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 15, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Duhay Francis sold 11 shares at $11.21 (≈$123) on Sep 11, 2026
- Duhay Francis sold 11 shares at $11.21 (≈$123) on Sep 11, 2026
- Duhay Francis sold 11 shares at $11.21 (≈$123) on Sep 11, 2026
- Duhay Francis sold 11 shares at $11.21 (≈$123) on Sep 11, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 11, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 21, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 30, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$3.60M (prior year -$6.69M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$5.37 (prior year -$11.52) (loss narrowed vs Jun 30, 2025)
Jul 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade NVNO
- Last results release: Apr 29, 2026 (8-K Item 2.02). Previous ones: Feb 4, 2026, Mar 13, 2019. Based on that rhythm, the next report is likely around Jul 29, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.54% (largest 9.6%). That is a volatile stock.
- Liquidity: about 31.06K shares (≈$232.02K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $7.47 vs a range of $7.01–$28.70 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:35 on Jan 20, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 16 sales; latest: Francis Duhay sold 11 shares on Sep 11, 2026.
- Latest filings: 10-Q Jul 30, 2026; 8-K Jul 14, 2026; 10-Q May 6, 2026.
- Share count: 682.72K shares outstanding (Jul 28, 2026), -96.5% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
NVNO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 8.01 | 8.01 | 7.30 | 7.47 | 67.60K |
| Oct 15, 2026 | 7.27 | 7.93 | 7.27 | 7.93 | 41.80K |
| Oct 14, 2026 | 8.00 | 8.13 | 7.18 | 7.40 | 18.90K |
| Oct 13, 2026 | 8.65 | 8.65 | 7.60 | 7.97 | 48.60K |
| Oct 12, 2026 | 8.80 | 8.80 | 8.06 | 8.15 | 122.90K |
| Oct 9, 2026 | 8.41 | 9.58 | 8.41 | 8.75 | 36.50K |
| Oct 8, 2026 | 8.41 | 8.48 | 8.06 | 8.18 | 6.70K |
| Oct 7, 2026 | 7.98 | 8.43 | 7.91 | 8.40 | 15.10K |
| Oct 6, 2026 | 8.01 | 8.47 | 7.96 | 8.20 | 36.80K |
| Oct 5, 2026 | 7.92 | 8.60 | 7.75 | 8.01 | 10.60K |
| Oct 2, 2026 | 8.11 | 8.78 | 7.70 | 8.10 | 24.30K |
| Oct 1, 2026 | 8.82 | 9.41 | 8.01 | 8.04 | 25.20K |
| Sep 30, 2026 | 8.53 | 9.00 | 7.80 | 7.80 | 122.40K |
| Sep 29, 2026 | 8.74 | 8.74 | 8.62 | 8.62 | 2.10K |
| Sep 28, 2026 | 8.81 | 8.81 | 8.81 | 8.81 | 1.00K |
| Sep 25, 2026 | 8.67 | 8.67 | 8.67 | 8.67 | 400 |
| Sep 24, 2026 | 8.61 | 9.09 | 8.61 | 9.09 | 700 |
| Sep 23, 2026 | 8.85 | 8.96 | 8.66 | 8.96 | 4.50K |
| Sep 22, 2026 | 8.91 | 9.11 | 8.86 | 9.10 | 10.00K |
| Sep 21, 2026 | 8.84 | 9.16 | 8.59 | 9.05 | 25.10K |
About enVVeno Medical
enVVeno Medical (NVNO) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in IRVINE, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1661053.
NVNO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Robert Andrew Berman | Chief Executive Officer | Dec 18, 2025 |
| Francis Duhay | Director | Sep 14, 2026 |
| Robert Gray | Director | Dec 15, 2025 |
| Matthew Jenusaitis | Director | Dec 15, 2025 |
| Sanjay Shrivastava | Director | Dec 15, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Hamed Alavi | Chief Technology Officer | Dec 18, 2025 |
| Robert Andrew Berman | Chief Executive Officer | Dec 18, 2025 |
| Marc H. Glickman | SVP & Chief Medical Officer | Dec 18, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 11, 2026 | Francis Duhay | Sale | 11 | $11.21 |
| Sep 11, 2026 | Francis Duhay | Sale | 11 | $11.21 |
| Sep 11, 2026 | Francis Duhay | Sale | 11 | $11.21 |
| Sep 11, 2026 | Francis Duhay | Sale | 11 | $11.21 |
| Jun 11, 2026 | Francis Duhay | Sale | 140 | $10.31 |
| Jun 11, 2026 | Francis Duhay | Sale | 140 | $10.31 |
| Jun 11, 2026 | Francis Duhay | Sale | 140 | $10.31 |
| Jun 11, 2026 | Francis Duhay | Sale | 140 | $10.31 |
| Mar 12, 2026 | Francis Duhay | Sale | 140 | $11.52 |
| Mar 12, 2026 | Francis Duhay | Sale | 140 | $11.52 |
| Mar 12, 2026 | Francis Duhay | Sale | 140 | $11.52 |
| Mar 12, 2026 | Francis Duhay | Sale | 140 | $11.52 |
| Dec 11, 2025 | Francis Duhay | Sale | 4,900 | $0.36 |
| Dec 11, 2025 | Francis Duhay | Sale | 4,900 | $0.36 |
| Dec 11, 2025 | Francis Duhay | Sale | 4,900 | $0.36 |
NVNO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-19.47M | -33.06 | $-15.57M |
| Dec 31, 2024 | — | $-21.82M | -44.53 | $-16.84M |
| Dec 31, 2023 | — | $-23.52M | -1.91 | $-18.86M |
| Dec 31, 2022 | — | $-24.67M | -2.20 | $-15.62M |
| Dec 31, 2021 | — | $-16.53M | — | $-11.85M |
Latest balance sheet: total assets $22.66M, total liabilities $1.99M, cash $2.84M (as of Jun 30, 2026).
NVNO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Apr 29, 2026 | 8-K Item 2.02 (results) | $10.71 |
| Feb 4, 2026 | 8-K Item 2.02 (results) | $9.39 |
| Mar 13, 2019 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on NVNO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.